Sen. Grassley Questions FDA’s Response To Acetaminophen Concerns
This article was originally published in The Tan Sheet
Executive Summary
Sen. Chuck Grassley, R-Iowa, asks FDA to account for its lag time in reacting to acetaminophen safety concerns in a March 20 letter to Commissioner Andrew von Eschenbach